Literature DB >> 1943863

Pathophysiological mechanisms involved in genesis and spread of muscular tension in occupational muscle pain and in chronic musculoskeletal pain syndromes: a hypothesis.

H Johansson1, P Sojka.   

Abstract

This paper introduces a pathophysiological model for the cause of muscular tension and pain in occupational pain syndromes and chronic muskuloskeletal pain syndromes, which also might clarify why these conditions have a tendency to perpetuate themselves and spread from one muscle to another. The model can briefly be described as follows. Metabolites produced by (static) muscle contractions stimulate group III and IV muscle afferents, which activate gamma-motoneurones projecting to both homonymous and heteronymous muscles. The gamma-motoneurones influence the stretch sensitivity and discharges of secondary and primary spindle afferents. Increased activity in the primary muscle spindle afferents enhances the muscle stiffness, which leads to further production of metabolites in both homo- and heteronymous muscles. Increased activity in secondary spindle afferents, which project back to the gamma system, constitutes a 'built in' second positive feedback loop which may perpetuate the condition with less 'support' from activity in group III and IV muscle afferents.

Entities:  

Mesh:

Year:  1991        PMID: 1943863     DOI: 10.1016/0306-9877(91)90233-o

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  58 in total

1.  Assessment of muscular tension in children.

Authors:  Gösta Alfven
Journal:  Int J Behav Med       Date:  2003

2.  Infrared thermography for examination of skin temperature in the dorsal hand of office workers.

Authors:  Judith E Gold; Martin Cherniack; Bryan Buchholz
Journal:  Eur J Appl Physiol       Date:  2004-08-25       Impact factor: 3.078

3.  Effect of sex on preactivation of the gastrocnemius and hamstring muscles.

Authors:  R G DeMont; S M Lephart
Journal:  Br J Sports Med       Date:  2004-04       Impact factor: 13.800

4.  Visceral and somatic disorders: tissue softening with frequency-specific microcurrent.

Authors:  Carolyn R McMakin; James L Oschman
Journal:  J Altern Complement Med       Date:  2012-07-09       Impact factor: 2.579

5.  Association of electromyographic activation patterns with pain and functional disability in people with chronic neck pain.

Authors:  Sharon M H Tsang; Grace P Y Szeto; Y F Xie; Raymond Y W Lee
Journal:  Eur J Appl Physiol       Date:  2018-05-05       Impact factor: 3.078

6.  Comparison of the electromyographic activity in the upper trapezius and biceps brachii muscle in subjects with muscular disorders: a pilot study.

Authors:  E Schulte; L A C Kallenberg; H Christensen; C Disselhorst-Klug; H J Hermens; G Rau; K Søgaard
Journal:  Eur J Appl Physiol       Date:  2005-02-04       Impact factor: 3.078

7.  Neuromuscular assessment in elderly workers with and without work related shoulder/neck trouble: the NEW-study design and physiological findings.

Authors:  G Sjøgaard; K Søgaard; H J Hermens; L Sandsjö; T Läubli; S Thorn; M M R Vollenbroek-Hutten; L Sell; H Christensen; A Klipstein; R Kadefors; R Merletti
Journal:  Eur J Appl Physiol       Date:  2005-09-29       Impact factor: 3.078

8.  Differential effects of mental load on proximal and distal arm muscle activity.

Authors:  Jules G Bloemsaat; Ruud G J Meulenbroek; Gerard P Van Galen
Journal:  Exp Brain Res       Date:  2005-08-03       Impact factor: 1.972

9.  Effects of experimental muscle pain on shoulder-abduction force steadiness and muscle activity in healthy subjects.

Authors:  Thomas Bandholm; Lars Rasmussen; Per Aagaard; Louise Diederichsen; Bente Rona Jensen
Journal:  Eur J Appl Physiol       Date:  2007-12-08       Impact factor: 3.078

10.  Changes in the degree of motor variability associated with experimental and chronic neck-shoulder pain during a standardised repetitive arm movement.

Authors:  Pascal Madeleine; Svend Erik Mathiassen; Lars Arendt-Nielsen
Journal:  Exp Brain Res       Date:  2007-11-20       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.